← Back to Search

Palliative and Oncology Care for Breast Cancer

N/A
Waitlist Available
Led By Jennifer Temel, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test whether a new way of delivering oncology and palliative care, where the two teams work together, leads to better communication and improved quality of life for patients with metastatic breast cancer.

Eligible Conditions
  • Metastatic Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
End of life care preference documentation
Secondary outcome measures
Chemotherapy at the end of life
Length of stay on hospice
Patient-reported anxiety symptoms (Hospital Anxiety and Depression Scale)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Palliative and oncology care modelExperimental Treatment1 Intervention
After the screening procedure confirm eligibility to participate in the research study. Participants will be randomized into one of two study groups; -- Standard oncology care with palliative care.
Group II: Standard oncology careActive Control1 Intervention
After the screening procedure confirm eligibility to participate in the research study. Participants will be randomized into one of two study groups; -- Standard oncology care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Palliative and Oncology Care
2016
N/A
~120

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,931 Previous Clinical Trials
13,198,325 Total Patients Enrolled
81 Trials studying Breast Cancer
132,912 Patients Enrolled for Breast Cancer
National Comprehensive Cancer NetworkNETWORK
115 Previous Clinical Trials
7,515 Total Patients Enrolled
3 Trials studying Breast Cancer
428 Patients Enrolled for Breast Cancer
Jennifer Temel, MDPrincipal InvestigatorMassachusetts General Hospital
11 Previous Clinical Trials
5,304 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current vacancies in this medical research endeavor?

"Clinicaltrials.gov states that this investigation is no longer enrolling participants, despite being updated on September 15th 2021. Despite this, there are still 2,301 other medical studies searching for volunteers at the present time."

Answered by AI
Recent research and studies
Journal of the National Comprehensive Cancer NetworkJournal
Randomized Trial of a Palliative Care Intervention to Improve End-of-life Care Discussions in Patients with Metastatic Breast Cancer
Greer, Joseph A., Beverly Moy, Areej El-Jawahri, Vicki A. Jackson, Mihir Kamdar, Juliet Jacobsen, Charlotta Lindvall, et al.. 2022. “Randomized Trial of a Palliative Care Intervention to Improve End-of-life Care Discussions in Patients with Metastatic Breast Cancer”. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC. doi:10.6004/jnccn.2021.7040.
clinicaltrials.govStudy
Palliative And Oncology Care Model In Breast Cancer
Jennifer Temel, MD 2016. "Palliative And Oncology Care Model In Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02730858.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top